Literature DB >> 11442513

Clinical monitoring after cessation of enzyme replacement therapy in M. Gaucher.

S vom Dahl, L W Poll, D Häussinger.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11442513     DOI： 10.1046/j.1365-2141.2001.02821-9.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  4 in total

1.  Effects of switching from a reduced dose imiglucerase to velaglucerase in type 1 Gaucher disease: clinical and biochemical outcomes.

Authors:  Laura van Dussen; Timothy M Cox; Erik J Hendriks; Elizabeth Morris; Erik M Akkerman; Mario Maas; Johanna E M Groener; Johannes M F G Aerts; Patrick B Deegan; Carla E M Hollak
Journal:  Haematologica       Date:  2012-07-06       Impact factor: 9.941

2.  Did the temporary shortage in supply of imiglucerase have clinical consequences? Retrospective observational study on 34 italian Gaucher type I patients.

Authors:  Laura Deroma; Annalisa Sechi; Andrea Dardis; Daniela Macor; Giulia Liva; Giovanni Ciana; Bruno Bembi
Journal:  JIMD Rep       Date:  2012-07-01

Review 3.  The role of the iminosugar N-butyldeoxynojirimycin (miglustat) in the management of type I (non-neuronopathic) Gaucher disease: a position statement.

Authors:  T M Cox; J M F G Aerts; G Andria; M Beck; N Belmatoug; B Bembi; R Chertkoff; S Vom Dahl; D Elstein; A Erikson; M Giralt; R Heitner; C Hollak; M Hrebicek; S Lewis; A Mehta; G M Pastores; A Rolfs; M C Sa Miranda; A Zimran
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

4.  Treatment Efficiency in Gaucher Patients Can Reliably Be Monitored by Quantification of Lyso-Gb1 Concentrations in Dried Blood Spots.

Authors:  Claudia Cozma; Paskal Cullufi; Guido Kramp; Marina Hovakimyan; Virtut Velmishi; Agim Gjikopulli; Sonila Tomori; Steffen Fischer; Sebastian Oppermann; Ulrike Grittner; Peter Bauer; Christian Beetz; Arndt Rolfs
Journal:  Int J Mol Sci       Date:  2020-06-27       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.